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Abstract
Mammary gland development starts in utero with one or several pairs of mammary rudiments (MRs) budding from the
surface ectodermal component of the mammalian embryonic skin. Mice develop five pairs, numbered MR1 to MR5 from
pectoral to inguinal position. We have previously shown that Gli3
Xt-J/Xt-J mutant embryos, which lack the transcription factor
Gli3, do not form MR3 and MR5. We show here that two days after the MRs emerge, Gli3
Xt-J/Xt-J MR1 is 20% smaller, and
Gli3
Xt-J/Xt-J MR2 and MR4 are 50% smaller than their wild type (wt) counterparts. Moreover, while wt MRs sink into the
underlying dermis, Gli3
Xt-J/Xt-J MR4 and MR2 protrude outwardly, to different extents. To understand why each of these five
pairs of functionally identical organs has its own, distinct response to the absence of Gli3, we determined which cellular
mechanisms regulate growth of the individual MRs, and whether and how Gli3 regulates these mechanisms. We found a 5.5
to 10.7-fold lower cell proliferation rate in wt MRs compared to their adjacent surface ectoderm, indicating that MRs do not
emerge or grow via locally enhanced cell proliferation. Cell-tracing experiments showed that surface ectodermal cells are
recruited toward the positions where MRs emerge, and contribute to MR growth during at least two days. During the
second day of MR development, peripheral cells within the MRs undergo hypertrophy, which also contributes to MR
growth. Limited apoptotic cell death counterbalances MR growth. The relative contribution of each of these processes
varies among the five MRs. Furthermore, each of these processes is impaired in the absence of Gli3, but to different extents
in each MR. This differential involvement of Gli3 explains the variation in phenotype among Gli3
Xt-J/Xt-J MRs, and may help to
understand the variation in numbers and positions of mammary glands among mammals.
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Introduction
In mouse embryos, five pairs of mammary rudiments (MRs)
arise asynchronously between embryonic day (E) 11 and E12,
along a pair of histologically and molecularly distinct ‘mammary’
lines (ML) of ectoderm; one line on each flank, extending between
axilla and inguen along the ventro-lateral boundary of the flank
[1]. Initially disk-shaped multilayered placodes, MRs grow rapidly
and become bud- or bulb-shaped within 2 days [2]. While the
ectodermal origin of MRs has been demonstrated [3], the cellular
mechanisms orchestrating the formation and early growth of MRs
remain ill-understood.
The few studies focusing on unraveling these mechanisms leave
caveats. For example, Balinsky tested whether murine MRs grow
by enhanced cell proliferation. Due to technical limitations of his
time, he had to pool MRs - all or a subset, that’s unclear - from
E11 to E14 embryos for statistical analysis, and found a significant
3.5-fold lower fraction of mitotic cells within the MRs compared to
pooled ectoderm and epidermis [4]. He therefore suggested that
MRs do not grow by cell proliferation, but by recruitment of
ectodermal cells, most likely via centripetal aggregation [5].
However, he neither demonstrated ectodermal recruitment, nor
investigated whether the lower mitotic index of MRs simply
reflected the negatively allometric growth of MRs with the embryo
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recruit ectodermal cells, as charcoal distributed on but not
adjacent to the ridge-like ML of E13 rabbit embryos, is
incorporated into the emerging MRs over a period of 24–48 hours
[6]. Propper therefore concluded that ectodermal cells migrate
along the mammary ridge to accumulate into the MRs. Contrary
to the concept of centripetal aggregation, Propper proposed cell
migration along the length of the mammary ridge, by attributing
migratory properties to superficial spindle-like cells aligning with
the length of the mammary ridge of fixed rabbit embryos [7].
Following the molecular identification of a ML in the mouse
embryo [1], Propper’s concept of cell migration along the ML as a
mechanism of MR growth was extrapolated to the mouse embryo,
by comparing TOPGAL-expressing cells along the surface of the
murine ML to the spindle-like cells on the rabbit’s mammary ridge
[8]. However, such extrapolation may not be justified, because of
several differences in early mammogenesis between mouse and
rabbit. For example, the murine ML is much thinner than the
rabbit’s mammary ridge; it becomes histologically and molecularly
distinct almost simultaneously with, instead of prior to the
appearance of the MRs as occurs in rabbit; the murine MRs
appear as elevated domes along the ML while in rabbit, MRs are
left behind as residual peaks following subsidence of the mammary
ridge; and the murine ML disappears relatively early compared to
the developmental stage of the MRs [1,5,6,9]. Thus, in mouse, the
ML may be unable to provide sufficient cells to account for MR
growth. Yet to what extent ectodermal recruitment does
contribute to murine MR growth, and whether alternative cellular
mechanisms of growth are involved, has not been explored.
We previously suggested that different molecular requirements
for mammary induction may exist along the ML [2]. This
suggestion is now supported by the regional instead of global
effects along the ML of at least 10 mutated genes
[9,10,11,12,13,14,15]. For example, similar to Xt-mutants [16],
Gli3
Xt-J/Xt-J null mutants of the transcription factor Gli3 [17] fail to
induce MR3 and 5, but not MR1, 2 and 4 [9,18,19]. Because such
different molecular mechanisms of the individual MRs may
culminate into different cellular mechanisms driving MR induc-
tion and early growth, each MR should be examined individually
to fully understand mammary development.
Here we report growth defects in Gli3
Xt-J/Xt-J MR1, MR2 and
MR4, coinciding with the daily switching morphogenetic stages.
To determine the cause of stunted growth of Gli3
Xt-J/Xt-J MR1,
MR2 and MR4, we considered that growth may be mediated by
cell proliferation, hypertrophy, cell survival, recruitment from
adjacent ectoderm, or a combination of these events. As these
mechanisms may vary per MR and morphogenetic stage, we
examined all MR pairs as separate entities and at discrete days.
We developed image analysis algorithms to quantify the early
growth rates and proliferation rate by BrdU-incorporation, and to
generate 3D-reconstructions of the individual MRs. We found
#4.5% BrdU-incorporation within 2 hours in the growing MRs,
indicating that proliferative activity is too low to explain MR
growth. While we faced experimental obstacles to assay cell
migration via time-lapse video-analysis, this low BrdU-incorpora-
tion enabled us to use incorporated BrdU as a cell tracer at
24 hours after labeling. We detected that ectodermal cells,
recruited mostly if not all from outside the ML, contribute
significantly to growth of all MRs during the first day of mammary
development. Cell hypertrophy is a major growth contributor
during the second day. We identified a role for Gli3 in cell
proliferation, survival, migration, and hypertrophy, and differenc-
es therein among the MRs themselves and in their adjacent tissues.
Such rudiment-specific molecular regulation of shared cellular
mechanisms provides a beginning to the understanding of
patterning and early growth of MRs within the ectoderm, and
may have to be taken into consideration in studies of postnatal
mammary gland development and tumorigenesis.
Materials and Methods
Mice and Ethics Statement
Gli3
Xt-J/+ mice on a C57BL/6J background (Jackson Labora-
tories, stock 000026) were bred and kept in strict accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. Steps
were taken to minimize suffering. The research protocol was
approved by the Institutional Animal Care and Use Committee of
Childrens Hospital Los Angeles (permit 29-02 to SB) and A*STAR
Biological Resource Centre (permits 060204 and 090463 to JMV).
Gli3
Xt-J/Xt-J embryos from timed Gli3
Xt-J/+ intercrosses, with noon
of the day of vaginal plug appearance considered as E0.5, were
genotyped as described [17].
Section in situ hybridization
4% PFA-fixed embryos were paraffin embedded (=PFPE) and
transversally sectioned at 8 mm thickness for in situ hybridization
with a
35S-labeled Gli3 antisense probe as described [20].
Micro-array analysis
Embryos were harvested in RNA-later (Ambion). Ectoderm and
mammary epithelium were separated from the mesenchyme by
microsurgical techniques (Sun et al., in preparation). Minimal
tissue cross-contamination was confirmed by analysis of tissue-
specific transcript expression. We generated five E12.5 and two
E13.5 independent pools of the five mammary rudiment (MR)
pairs, ectoderm and mesenchyme respectively of at least five
embryos. Per pool, 10 ng of high-quality RNA, extracted with the
RNeasy Micro Plus Kit (Qiagen), was amplified with WT-
Ovation
TM Pico System to produce labeled cDNA (NuGene
Technologies, Inc.) for hybridization to Affymetrix Mouse Gene
1.0 ST micro-array chips. Data were analyzed with the Partek
Genomics Suite.
Immunohistochemical detection of BrdU incorporation
Day 11.5 to 13.5 pregnant mice were injected intraperitoneally
with 1 ml/100 g bodyweight BrdU (Amersham). Embryos were
harvested at 2 or 24 hours post-injection, methanol-Carnoy’s-fixed
(60%MeOH/30%HCl3/10%HAc), paraffin embedded (=MCFPE),
and transversally sectioned at 5–6 mm thickness. BrdU-incorporation
was detected with anti-BrdU (1:100, Amersham), anti-mouse HRP
(1:500, Jackson), and the substrate diaminobenzidine. Substrate
conversion was stopped at saturation, but before background signal
developed. Slides were counter-stained with Harris hematoxylin
(Sigma-Aldrich). Figure panels show the central section of represen-
tative MRs.
Apoptotic cell detection
TUNEL assays were performed on 5 or 6 mm sections of PFPE
or MCFPE embryos with the in situ cell death detection kit
(Roche). Figure panels show the central section of representative
MRs.
Quantitation of BrdU incorporation
We developed algorithms in Matlab R2008b (Mathworks) to
quantify BrdU-labeling in digital images loaded into Metamorph
7.5.1 (Molecular Devices Corp.). First, digital images were
Differential Roles for Gli3 in Mammary Growth
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membrane of the ectoderm; around the MR and its neck if
present. An automatic active contour [21,22] further segmented
the ectoderm from the background. The MR-contour was
automatically congruently dilated, and in the central sections also
eroded [23] with empirically determined parameters: A 15 mm
dilation included the few layers of mammary mesenchyme that
differentiate from the surrounding dermal mesenchyme by
condensation and Androgen Receptor expression between E12.5
and E13.5 [24]; and erosion to yield a 1:3 area ratio coincides with
histological and immuno-chemical differences between cuboidal
core cells and larger columnar peripheral cells at bud-stage. A
manually drawn line segmented the mammary mesenchyme of
Gli3
Xt-J/Xt-J MR2. Two automatically placed lines parallel to the
ectoderm - one through the center of the MR and the other 65 mm
below it - were empirically determined to include dermal
mesenchyme while excluding the somites and some laterally
extending mammary mesenchyme around the top half of each
MR at E13.5. The algorithms returned quality control images for
verification of segmentation. Manual color thresholding segment-
ed BrdU
+ve nuclei and all nuclei within the images. Numerical
output on total nuclear and BrdU
+ve areas per segment were
written to an Excel file.
Volume measurements
Using our abovementioned software, the area (in mm
2)o f
mammary epithelium was quantified in consecutive sections
through entire MRs of MCFPE embryos. We developed a
software in C programming language on CentOS 5.3 (http://
www.centos.org) to plot values against cumulative section
thickness, apply Levenberg-Marquardt curve-fitting [25] to reduce
errors created by lost sections, and then determine the MR volume
as the area under the fitted curve.
Statistical analysis
Unless indicated otherwise, MRs of one or both flanks of wt and
Gli3
Xt-J/Xt-J littermates from at least 3 different litters were used
per age-group. Data are represented as mean 6 standard
deviation. Asterisks in bar graphs indicate a significant difference
(p,0.05) between samples connected by a horizontal bracket, as
tested with Student’s t-test if BrdU-exposure conditions were
different (e.g. comparing 2 h and 24 h post labeling), or a paired
Student’s t-test if BrdU-exposure conditions were the same (e.g
comparing littermates, or tissues within specimens). Significance of
differences among all MRs was tested with ANOVA.
3D-reconstruction of the MRs
We manually segmented (labeled) the ectoderm and MR in
each image using segmentation editor in Fiji (http://pacific.mpi-
cbg.de/wiki/index.php/Fiji). Algorithms were developed in Ma-
tlab R2008b and R2010b (Mathworks) to determine two
transformation control points in the ectoderm in addition to the
MR-center. These three points were used to align consecutive
images with the first image of the stack via non-reflective similarity
transformation [26]. The aligned original image-stacks were
converted to inverted grayscale from 0 to 1.0, after which the
black (BrdU
+ve) pixels were segmented from the background using
an empirically determined fixed threshold value of 0.65. With a `
priori knowledge of the approximate nuclear size, we eliminated
noise or artifacts. Touching nuclei were split using the Evolving
Generalized Voronoi Diagram algorithm [27]. Aligned labeled
images and segmented original images served to generate 3D iso-
surfaces of ectoderm, MR, and BrdU
+ve nuclei, in different
superimposed transparent colors.
Results
Each Gli3
Xt-J/Xt-J mammary rudiment pair has a unique
phenotype
We previously reported that Gli3
Xt-J/Xt-J mutants fail to induce
MR3 and MR5 at E11.5 [9,18]. Current analysis revealed that
Gli3
Xt-J/Xt-J MR1 is slightly, and MR2 and MR4 are obviously
smaller than their wild type (wt) (Fig. 1A–H) or heterozygous (not
shown) counterparts at E13.5. At E12.5, Gli3
Xt-J/Xt-J MR2 and
MR4 look like placodes instead of hillocks; and by E13.5 MR4
has a mild, and MR2 a severe invagination defect (Fig. 1 A–H,
2A–Y). Whereas MR4 does invaginate by E15.5 and forms an
ectodermal indentation preceding formation of an outlet of the
milk canal (not shown), MR2 continues to grow outwardly
without forming an outlet (Fig. 1I,J). Nonetheless, Gli3
Xt-J/Xt-J
MR2 undergoes nipple formation, sprouting and branching
morphogenesis before E18.5, as do MR4 (Fig. 1K–N) and MR1
(not shown). In conclusion, each of the developing Gli3
Xt-J/Xt-J
MRs has a distinct phenotype.
In serial histological sections, we measured MR size between
E11.75 - when all wt MRs except MR5 can be accurately
segmented from the ectoderm - and E13.5 - when the main
growth defect has occurred. At E11.75, wt MRs vary in size
between 6.2610
4 mm
3 (MR2) and 13610
4 mm
3 (MR3) in
accordance with MR3 emerging before MR2 [1,18]. All MRs
grow at different rates (Fig. 1O), to attain a size of 2.6–
4.0610
5 mm
3 by E13.5 (Table 1). The developing Gli3
Xt-J/Xt-J
MRs are about J day delayed in their onset, and MR4 is initially
so flat that it can only be reliably segmented from the ectoderm
from E12.5 onwards. MR1 grows normally, but does not
compensate for the delayed start and remains about 20% smaller
than in wt. Gli3
Xt-J/Xt-J MR2 and MR4 grow slowly, such that by
E13.5 they are ,50% smaller than in wt, and even smaller than
E12.5 wt MRs (Fig. 1O).
In situ hybridization revealed no detectable Gli3 expression in
the ectoderm or the emerging epithelium of mammary line (ML)
and placodes at around E11.5, but high expression in the
thoracic and lumbar somites and delaminating dermal mesen-
chyme [9]. Thus, the initial growth defect of the Gli3
Xt-J/Xt-J
MR1, MR2 and MR4 is likely due to loss of Gli3 in these
mesodermal derivatives and consequently disturbed interactions
with the ectoderm. However, by E12.5 and E13.5, Gli3 is
detectable in situ in the (prospective) mammary mesenchyme,
ectoderm, and mammary epithelium (Fig. 1P–U9). Micro-array
analysis of separated tissues at these ages confirms this mRNA
expression profile (Fig. 1V), which is also consistent with the
Gli3 protein expression profile at E13.5 [19]. Thus, the initial
growth defects of Gli3
Xt-J/Xt-J MR2 and MR4 at E11.5 could
subsequently be compounded by the lack of Gli3 in any of the
tissue compartments.
Peripheral cells in Gli3
Xt-J/Xt-J MR2 and MR4 fail to
differentiate into large columnar cells
Slightly before E12.5, peripheral cells within wt MR1, wt MR3
and Gli3
Xt-J/Xt-J MR1 undergo hypertrophy and become colum-
nar (Fig. 2G,I,T), associated with altered protein expression levels
(not shown), while cells in the ectoderm and core of these MRs
remain cuboidal. During the following day, hypertrophy also
occurs inperipheralcellsoftheotherwtMRs,butnot ofGli3
Xt-J/Xt-J
MR2 and MR4 (Fig. 1A–H, 2A–Y). The hypertrophy-mediated
volume increase of MRs can be estimated by considering a MR as a
sphere with a realistic radius r of 5 cell-diameters and with the outer
cell doubling its diameter in 1 day (thus r=6 cell diameters). Then
Differential Roles for Gli3 in Mammary Growth
PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e26242Figure 1. Relationship between Gli3 expression and mammary rudiment growth in mouse embryos. A–H: Hematoxylin/Eosin stained
central transversal sections through MRs. Black contours in B surround the MR (solid) and mammary mesenchyme (dotted). Scale-bar in A: 100 mmi n
A–H. I–J: Scanning electron micrographs showing the outlet of the prospective milk-canal in a wt MR2, and the outwardly protruding Gli3
Xt-J/Xt-J MR2
at E15.5. K–N: Carmine-stained skins. Arrowheads indicate some end buds (white) and the nipple (black). O: Volumetric growth curve of MRs. P–U9:
Bright-field images of wt MRs and corresponding dark-field images with the radio-active in situ hybridization signal of a Gli3 mRNA probe in white. V:
Quantification of Gli3 expression in micro-array data of each MR, ectoderm (Ect) and mesenchyme (Mes). Dashed error-bars at E13.5 extend between
n=2 measurements.
doi:10.1371/journal.pone.0026242.g001
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4P
3
|r3

would increase
4P=3|63
4P=3|53<1.7
fold, which corresponds reasonably well with the observed growth
between E12.5 and E13.5 (Table 1). Given the observed shape
changes between E12.5 and E13.5 (Fig. 2), this calculation probably
yields an overestimation, but indicates nonetheless that hypertrophy
into columnar cells may contribute considerably to MR growth
between E12.5 and E13.5. Hence, the lack of hypertrophic
differentiation in Gli3
Xt-J/Xt-J MR2 and MR4 by E13.5 (Fig. 1G,H,
2X,Y) may explain, at least partly, the reduced growth of these MRs
between E12.5 and E13.5.
Emergence and growth of the MRs is not mediated by
enhanced cell proliferation
But what explains the smaller size of Gli3
Xt-J/Xt-J MR2 and
MR4 at E12.5, before hypertrophy should occur? Histological
examination readily visualizes that their smaller size is mainly due
to a reduced cell number, or hypoplasia (Figs. 2H,U; 2J,V). To
address whether this reflects a proliferation defect, we first
determined to what extent cell proliferation contributes to MR
growth in wt embryos. We labeled cells in S-phase with BrdU.
Transversal sections of E11.25 (or 42 somite-stage) to E13.5
embryos reveal that the ML and MRs contain strikingly few
BrdU
+ve cells compared to their flanking ectoderm (Fig. 2A–Y).
Thus, ectodermal multilayering during ML and subsequent MR
formation are not a consequence of locally enhanced cell
proliferation.
To quantify proliferation rates, we developed image analysis
algorithms to segment images of histological sections in MRs (with
neck, periphery and core), ectoderm, dermal and mammary
mesenchyme, and in BrdU
+ve and hematoxylin
+ve areas. The
algorithms generated quality control images displaying all
segmentation boundaries, for visual inspection of segmentation
and validity of the numerical output regarding relative BrdU-
content of segments (Fig. 2Z).
The ratio of BrdU
+ve pixels among all nuclear (BrdU
+ve+he-
matoxylin
+ve) pixels serves as a proxy for proliferation rate. In
embryos younger than E11.75, most MRs are too flat for
accurate segmentation. In wt MRs larger than 10610
4 mm
3
(Fig. 2AA), i.e. at E12 and older (Fig. 1O), the average
proliferation rate appears relatively constant, as is the case in
Gli3
Xt-J/Xt-J MRs at all volumes (Fig. 2AB). We therefore
excluded a need to correct for differences in developmental stage
of the MR at any chronological age of embryos, and henceforth
grouped the data by chronological age.
The proliferation rate within wt MRs is very low: 4.5%62.4 at
E12.5 and 3.3%61.5% at E13.5 (Fig. 2AD, AE), and varies
significantly among MRs (p=0.0002 at E12.5; p=0.0007 at
E13.5). Notably, between E12.5 and E13.5, the mean proliferation
rate within MRs decreases from 5.5 to 10.7-fold lower (p,0.0001)
than the relatively constant rate of 22%65% (p.0.09) in the
adjacent ectoderm (Table 2). As Balinsky had concluded that as a
pool, MRs grow negatively allometric with the embryo between
E11 and E14 [4], we now asked whether this is true for individual
MRs and on a day-to-day basis, and whether the relatively low
proliferation rate in MRs would simply reflect such negatively
allometric growth. We found that between E11.75 and E12.5,
most MRs grow negatively allometric. However, MR2 then grows
almost isometrically (2.5 versus 2.7 fold increase), and like MR4,
grows positively allometric between E12.5 and E13.5 (Table 1).
Therefore, proliferation rates of at least these MRs are too low to
account entirely for their growth.
How much does proliferation contribute to wt MR growth? As
the surface ectoderm of the trunk remains single-layered before
E13.5, its proliferative activity must be approximately isometric
with growth of the entire embryo. With e.g. the cells of MR2
having a 5.9-fold lower proliferation rate than the ectoderm
(Table 2), proliferation may account for (
2:7=2:5
5:9
)<18% of the
growth of this MR at E12.5, declining to (
1:6=2:1
24:8
)<3% by E13.5.
Similarly, the contribution of proliferation to MR growth may
decline from ,15%–44% to ,3%–19% over 2 days in a
rudiment-specific manner. Based on these rough estimates, we
conclude that MRs grow neither entirely nor primarily by cell
proliferation, and that cell proliferation contributes progressively
less to MR growth between E11.5 and E13.5. The declining
proliferation rates between E12.5 and E13.5 contrasting the steady
or increased growth rate of MRs during this day (Fig. 1O), and the
lower proliferation rate in MR2 and MR4 (Fig. 2AD, AE) despite
their faster growth than MR1 and MR3 during this day (Fig. 1O),
support this conclusion.
Hypoplasia of Gli3
Xt-J/Xt-J MRs is not due to defective
epithelial proliferation, and concurs with failure to
downregulate mesenchymal proliferation
Interestingly, Gli3
Xt-J/Xt-J MRs display hypoplasia despite their
normal or increased proliferation rate at E12.5 (p=0.012 for
MR2) and E13.5 (Fig. 2AD,AE). Given that Balinsky had
suggested that the MRs grow due to cell aggregation from the
adjacent ectoderm [5], we assessed whether the Gli3
Xt-J/Xt-J
Table 1. Growth comparison of mammary rudiment volume to embryonic weight in wt E11.75–E13.5 mouse embryos.
VE11.75 (n)V E12.5 (n)V E13.5 (n)V E12.5/VE11.75 VE13.5/VE12.5 VE13.5/VE11.75
MR 1 9.860.8 (4) 22.165.1 (16)3 3 . 6 68.1 (13) 2.3 1.5 3.4
MR 2 6.261.9 (2) 15.563.6 (14)3 2 . 1 66.4 (14) 2.5 2.1 5.2
MR 3 13.163.5 (8) 20.265.5 (14)3 4 . 5 610.2 (13) 1.5 1.7 2.6
MR 4 9.663.7 (6) 19.167.9 (17)4 0 . 2 68.3 (14) 2.0 2.1 4.2
MR 5 n.d 16.465.2 (15)2 6 . 5 67.4 (14) n.d 1.6 n.d
WE11.5 (n) WE12.5 (n) WE13.5 (n) WE12.5/WE11.5 WE13.5/WE12.5 WE13.5/WE11.5
Embryo 30.666.3 (6) 82.8613.3 (5) 134.6612.9 (14) 2.7 1.6 4.4
Embryos were dissected in PBS, dried with filter paper, and weighed with a mimimum of adhering PBS. Abbreviations: wt: wild type; V: Volume (610
4 mm); MR:
mammary rudiment; W: Weight (mg).
doi:10.1371/journal.pone.0026242.t001
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Indeed it does, as shown by the equal to perhaps increased
ectodermal proliferation rate in E11.75 Gli3
Xt-J/Xt-J embryos
compared to wt embryos (Fig. 2AC), and a rate similar to wt at
E12.5 and E13.5 near all MRs (Fig. 2AD, AE), with the statistically
significant difference near MR2 at E12.5 (p=0.025) perhaps being
biologically insignificant.
Of interest, the ectoderm between the limbs tends to have a
higher proliferation rate dorsally to the MRs, i.e. near MR2, MR3
and MR4, yet ventrally at the level of the forelimb (MR1) and
hindlimb (MR5) in wt (Fig. 2AI). The higher proliferation rate of
the ventral ectoderm seems to neutralize or switch towards a
higher dorsal proliferation rate by E13.5. However, few of these
differences are significant, giving no hint as to whether one side
may contribute more cells to the MRs than the other.
Furthermore, this tendency is not different in the Gli3
Xt-J/Xt-J
ectoderm.
Given the mesenchymal Gli3 expression (Fig. 1P–V), we also
assessed the mesenchymal proliferation rate. In E11.75 and E12.5
wt embryos, mesenchymal cells proliferate at a rate similar to
ectodermal cells (Fig. 2AC,AD,AF,AG), with no biologically and
statistically significant differences between dermal and ‘pre’mam-
mary mesenchyme except near MR5 at E12.5 (p=0.014)
(Fig. 2AG, AH). Between E12.5 and E13.5, a few layers of dermal
mesenchyme directly adjacent to the MR condense and express
the Androgen Receptor, marking their differentiation into
mammary mesenchyme [24]. This mesenchyme reduces its
proliferation rate less than the dermal mesenchyme by E13.5,
resulting in significantly different rates between dermal and
mammary mesenchyme near MR1, MR2 and MR3 (p=0.035,
0.038 and 0.012 respectively) (Fig. 2AH). The most prominent
difference in Gli3
Xt-J/Xt-J embryos is the significantly higher
proliferation rate of dermal mesenchyme than in wt near MR2
(p=0.035) and MR4 (p=0.011) due to a failure to slow down
proliferation between E12.5 and E13.5.
In conclusion, Gli3
Xt-J/Xt-J MR2 and MR4 are hypoplastic
despite having an initially higher proliferation rate than wt,
particularly in MR2. Furthermore, the loss of Gli3 changes cell
proliferation in the mammary epithelium and mesenchyme, and in
the adjacent ectoderm and dermal mesenchyme in a tissue-,
location-, and time-specific manner.
Hypoplasia of Gli3
Xt-J/Xt-J MRs 1, 2 and 4 is not caused by
epithelial apoptosis
We then assessed whether the hypoplasia of Gli3
Xt-J/Xt-J MRs
could be due to apoptosis. TUNEL-assays show different apoptotic
profiles among the five wt MR pairs, with MR5 showing a random
distribution within its epithelium, while the other rudiments show
mainly apoptotic cells at their apex or in their overlying periderm
at E12.5 (Fig. 3A–E). By E13.5, apoptosis occurs in a few cells in
the periderm overlying MR5, but not within wt MR1–4 (Fig. 3F–
J). At both ages, the surrounding ectoderm and mesenchyme show
virtually no apoptosis. Within the Gli3
Xt-J/Xt-J MRs or their
overlying periderm, apoptosis is strikingly less prominent to absent
at both ages (Fig. 3K–P). Thus, the marked hypoplasia of the
Gli3
Xt-J/Xt-J MRs by E13.5 occurs despite the prevention of
apoptosis in the epithelia. By contrast, while wt mammary and
dermal mesenchyme undergo virtually no apoptosis, the dermal
mesenchyme near E12.5 MR4 in Gli3
Xt-J/Xt-J mutants undergoes a
little. It remains possible that mesenchymal interactions with the
mammary epithelium are consequently disturbed, compromising
the growth of MR4.
Influx of ectodermal cells from outside the ML
contributes to MR formation and growth
Next we asked whether the MRs recruit ectodermal cells for
their growth. Unfortunately, the focal instability of flank cultures
rendered time-lapse video-analysis of deposited dyes like DiI, or of
conversion of the fluorescent substrate DDAOG, which visualizes
expression of the mammary epithelial marker TOPGAL, fruitless
for answering this question. However, the low and declining
proliferation rate (4.5% to 3.3%) of cells in the MRs between
E11.75 and E13.5 allowed us to BrdU-label embryos and track
labeled cells 24 hours later (t=24 h). A higher percentage of
BrdU
+ve cells in the MRs at t=24 h than at t=2 h (as used in our
proliferation assays) would be indicative of an influx of cells. In
accordance with BrdU being taken up by cells quickly or otherwise
degraded within 10–60 minutes [28], we did not observe a
significant increase in absolute number or ratio of BrdU
+ve pixels
in all tissues combined between t=2 h and t=24 h (Fig. 4Q,R).
This provides proof of principle that postponed harvest did not
prolong BrdU-labeling time in our experiments.
Given that all cells within the MRs are histologically and
biochemically similar before E12.5 (MR1 and MR3) or E13.5
(MR2, MR4 and MR5), we may assume that at least until then all
MR-cells are equal in cell cycle duration as well. Despite inheriting
only half the amount of BrdU, both daughters of a symmetrically
dividing BrdU
+ve cell each generate an equal number of BrdU
+ve
Table 2. Fold difference of ectodermal over mammary
epithelial proliferation rate in wt E11.5–E13.5 mouse embryos.
E11.5 (n) E12.5 (n) E13.5 (n)
MR1 3.5 (2) 4.5 (4) 5.5 (3)
MR2 1.3 (2) 5.9 (4) 24.8 (3)
MR3 5.6 (4) 4.0 (4) 6.5 (3)
MR4 2.5 (4) 8.9 (4) 8.1 (3)
MR5 4.2 (4) 8.5 (3)
Mean 3.2 5.5 10.7 (7.1 w/o MR2)
Numbers represent the mean ratios (Ectoderm/MR) as derived from the
statistics on BrdU-incorporation represented in Fig. 2AC–AE. Abbreviations: wt:
wild type; MR: mammary rudiment.
doi:10.1371/journal.pone.0026242.t002
Figure 2. Proliferative activity in wt and Gli3
Xt-J/Xt-J MRs and adjacent tissues. A–Y: Immunohistochemical detection of BrdU-incorporation
(black) at 2 hours post-labeling, with hematoxylin-counterstain (blue). Dashed yellow lines outline the MR. Left is ventral ectoderm, in some panels
indicated with *. Scale-bar in A: 100 mm in A–Y. Z-AI: Quantification of BrdU-incorporation in entire MRs and their adjacent tissues, represented in A–
Y. Z: Quality control image of a wt E13.5 MR1 as generated with our software. Colored outlines demarcate dorsal ectoderm (d.ect., green), ventral
ectoderm (v.ect., yellow), MR core (c, orange), MR periphery (p, red), MR neck (n, purple), mammary mesenchyme (m.m., turquoise), and dermal
mesenchyme (d.m., blue). AA,AB: Relationship between MR-volume and BrdU-incorporation. AC–AE: The BrdU
+ve fraction of all nuclear pixels in
MRs and their adjacent ectoderm. AF–AH: The BrdU
+ve fraction of all nuclear pixels in ‘pre’mammary or mammary and dermal mesenchyme (mes).
AI: Differences in BrdU-incorporation between the ventral and dorsal ectoderm (fraction in dorsal side subtracted from fraction in ventral side per
embryo). Asterisks denote a significantly difference (p,0.05) between both sides.
doi:10.1371/journal.pone.0026242.g002
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PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e26242Figure 3. Apoptosis in MRs and their adjacent tissues is regulated by Gli3. A–P: Epifluorescence images of TUNEL-stained (green) and DAPI-
counterstained (blue) central transversal sections through MRs, outlined by dashed white lines. Red insets: magnification of the apical area of the MR.
White insets: magnification of a TUNEL
+ve region in the mammary mesenchyme. Left is ventral ectoderm, in some panels indicated with *. Scale-bar in
A: 100 mm in A–P.
doi:10.1371/journal.pone.0026242.g003
Differential Roles for Gli3 in Mammary Growth
PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e26242Differential Roles for Gli3 in Mammary Growth
PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e26242pixels as their mother, because of saturation of the immuno-
precipitate. Thus, if the MRs would grow by cell proliferation
only, the ratio of BrdU
+ve pixels within the MRs at t=24 h should
fluctuate around the ratio at t=2 h, and never reach twice that
ratio, because unlabeled cells in M and G2 will divide prior to the
cells labeled in S-phase.
We observed a 2 to 4-fold higher ratio of BrdU
+ve cells in MRs
at t=24 h compared to t=2 h after labeling at E11.5 (p#0.012)
(Fig. 4S). The absolute number of BrdU
+ve pixels increased about
4-fold, varying per MR (p#0.003) (Fig. 4U). If this increase were
only due to mitosis of cells within the MRs, the MR volume should
increase 4-fold as well, especially for MR2 and MR4 that hardly
experience any cell apoptosis within them. Instead, these MRs
only double their size in that day, indicating MRs use mechanisms
other than cell proliferation alone to grow.
We infer that the increase of BrdU
+ve pixels is at least partly due
to an extensive influx of cells. Given the ectodermal origin of
mammary epithelium [3], the influxing cells must come from the
more densely labeled ectoderm. A mathematical approach
(Table 3) suggests that growth is approximately entirely due to
such influx. Since the ML connecting the prospective MRs 2–4 in
mouse embryos at around E11.5 is almost completely devoid of
BrdU
+ve cells, any influx of cells from along the ML into those
MRs would not be detected with our method. We can therefore
deduce from the observed BrdU
+ve influx that most of the
ectodermal cells recruited into the MRs by E12.5 were located
outside the ML at E11.5.
Between E12.5 and E13.5, the ratio of labeled pixels in wt MR4
(p=0.004) and MR5 (p=0.03) and the absolute number of
BrdU
+ve pixels in all wt rudiments still increases, but to a lesser
extent (Fig. 4T,V). Subdivision of the MRs into a core, periphery
and potential neck (i.e. in MR1-MR4 by E13.5), along with 3D-
renderings of MRs show that BrdU
+ve cells labeled at E12.5 are
predominantly located in the proximal region, i.e. neck if present,
of the MRs by E13.5 (Figs. 4F9–J9, 5A,B,G). In the absence of such
preferential proximal location at the time of labeling at E12.5
(Fig. 2G–P, 5G), these data strongly suggest that the increase of
BrdU
+ve cells is caused by a continued ectodermal influx between
E12.5 and E13.5.
Ectodermal influx is decreased in Gli3
Xt-J/Xt-J MRs 2 and 4
In Gli3
Xt-J/Xt-J MR1, the change in ratio, absolute number, and
location of BrdU
+ve pixels is similar to that in wt between E11.5
and E13.5 (Figs. 2A,G,Q,T; 4A,F,K,N,S–V; 5A–F) consistent with
a similar growth rate and morphogenesis as wt MR1 (Fig. 1O),
and indicating no perturbation of migration. By contrast, the ratio
of BrdU
+ve pixels in E12.5 Gli3
Xt-J/Xt-J MR2 and MR4 labeled at
E11.5 is almost as high as in wt (Fig. 4S), but their absolute
increase in pixels over 24 hours is at least 2-fold less than in wt
(Fig. 4U) despite an ectodermal labeling density similar to that in
wt (Fig. 2AC,AD). This indicates a strongly reduced influx of
ectodermal cells in Gli3
Xt-J/Xt-J MR2 and MR4 (Fig. 4L,M), which
accounts primarily for their hypoplasia seen at E12.5.
Between E12.5 and E13.5, the absolute number of BrdU
+ve
pixels increases slightly in these MRs (Fig. 4T). However, the
minimal growth of these MRs (Fig. 1O) and their failure to form a
neck or proximally accumulate BrdU
+ve cells (Fig. 4O,P; 5G)
indicate that ectodermal influx remains compromised, and may
suggest that the increase in BrdU
+ve pixels would mostly be due to
cell proliferation. Thus, continued compromised ectodermal influx
complements the lack of hypertrophy in Gli3
Xt-J/Xt-J MR2 and
MR4 between E12.5 and E13.5, explaining the persistent
hypoplasia of these MRs.
Discussion
To date, knowledge about the cellular mechanisms of early
mammary rudiment (MR) growth in the mouse embryo was based
largely on assumptions and controversial extrapolations. There-
fore, we here explored the nature of these mechanisms. In view of
the initially daily switching morphogenetic stages, and each of the
five MR pairs having a differential requirement for Gli3 for their
induction and development, we analyzed each of the MR pairs
individually, at discrete days, in wt and Gli3
Xt-J/Xt-J (null) mouse
embryos.
Relative contributions of ectodermal influx, proliferation,
apoptosis, and differentiation into hypertrophic
columnar cells, to mammary rudiment growth
In line with Balinsky’s data [4], we identified a lower
proliferation rate in the mammary epithelium compared to its
surrounding ectoderm. While Balinsky had pooled all - or an
unknown subset of - MRs of E11–E14.5 embryos for statistical
analysis, we show here that significant differences in proliferative
activity exist within each MR at E11.5, E12.5 and E13.5. At any of
those days, the MRs also differ significantly from each other in
proliferative activity. We provide three independent lines of
evidence that the proliferative activity is too low for MRs to grow
entirely, or even primarily, by cell proliferation between E11.5 and
E13.5:
1) the proliferation rate declines, contrary to the constant or
increasing growth rate of the MRs,
2) the average 5.5 to 10.7-fold lower proliferation rate of cells
within MRs compared to the ectoderm is inconsistent with
the only slightly negative or even positive allometric growth of
the MRs with the embryo between E11.5 and E13.5, and
3) the fold increase of BrdU
+ve cells at 24 h compared to 2 h
post-labeling at E11.5 is much greater than the fold increase
in MR volume in that time period.
We estimate that cell proliferation contributes initially ,15%–
44% to MR growth, declining to ,3%–19% between E12.5 and
E13.5, all in a rudiment-specific manner. Cell proliferation may
take on a more important role in MR growth between E14.5 and
E15.5 [29].
We demonstrate that MRs grow initially by an influx of
ectodermal cells. This influx is large during the first day,
accounting for all growth that is not mediated by cell proliferation
within the MRs. The influx decreases such that we estimate it to
contribute 22%–39% of MR growth between E12.5 and E13.5,
again in a rudiment-specific manner (see Table 3,
DVExp
DVObs). Ectoder-
Figure 4. Ectodermal influx provides growth of all MRs and is perturbed for Gli3
Xt-J/Xt-J MR2 and MR4. A–P: Immunohistochemical
detection of BrdU-incorporation (black) at 24 hours post-labeling, with hematoxylin-counterstain (blue). Panels F–J and F9–J9 show a random versus
primarily proximal distribution of labeled cells observed in 60% and 40% of wt MRs respectively. Dashed yellow lines outline the MR. Left is ventral
ectoderm, in some panels indicated with *. Scale-bar in A: 100 mm in A–P. Q–V: Quantification of BrdU-labeling in entire MRs and adjacent tissues
represented in A–P, by absolute number of BrdU
+ve pixels (Q) or BrdU
+ve fraction of all nuclear pixels (R) in all segmented tissues combined; or
BrdU
+ve fraction of all nuclear pixels (S,T) or absolute number (U,V) of BrdU
+ve pixels in the MRs.
doi:10.1371/journal.pone.0026242.g004
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+ve cells among individual MRs at E13.5. A–F: BrdU
+ve fraction of all nuclear pixels per MR
(y-axis), subdivided proportionally by distribution over core, periphery, and neck if present. G: 3D-reconstruction of MRs based on serial sections
stained for BrdU as in Figs. 2 and 5. Ectoderm/epidermis in green, with black BrdU
+ve nuclei; MR-epithelium in red , with blue BrdU
+ve nuclei.
doi:10.1371/journal.pone.0026242.g005
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previously published observation of similarly proximally located
labeled cells in E14.5 MRs in cultured flanks, labeled a day earlier
with [
3H]-thymidine [30].
Our results indicate that most of these influxing cells were
located outside the ML between E11.5 and E12.5, prior to their
incorporation in the emerging MRs in the course of 24 hours. Our
data may either support Balinsky’s suggestion of centripetal
aggregation of ectodermal cells toward the MR positions [5], or
the possibility that within those 24 hours, cells first migrate
towards the ML, and subsequently migrate along this line towards
the prospective MRs. The latter possibility may be supported by
the published observation that DiI-labeled ectoderm posterior to
the forelimb bud of a cultured E10 mouse embryonic flank
expanded in ventral-posterior direction over 72 hours [31].
However, since no time-lapse video-analysis was performed during
those 72 hours, it is unclear whether this expansion resulted from
cell proliferation and distortion of flanks during such long-term
culture or from ectodermal cell migration in dorso-ventral
direction and antero-posterior direction. If indeed the latter, then
our results would indicate that migration toward the ML and
along the ML would occur simultaneously in the mouse embryo.
This contrasts what happens in the rabbit embryo, where
formation of the mammary ridge seems to be temporally separated
from cell migration along the mammary ridge towards the
prospective MRs [6,7].
Based on our finding of the involvement of somitic Gli3 and
FGF10 in ML and MR3 formation, we previously suggested that
in between the forelimb and hindlimb, ectodermal cells may be
pulled along in dorso-ventral direction with the ventrally
elongating somites to form the ML [9]. Along that line of
thinking, our current finding of a higher proliferative activity -
albeit it not statistically significant – dorsally than ventrally to
MR2, MR3 and MR4, but not MR1 and MR5, is of interest: It
may suggest that the dorsal ectoderm in the interlimb region is
generating more cells to be pulled ventrally toward the mammary
line, while in the area of MR1 and MR5 another mechanism –
and directionality - of ectodermal recruitment may be active.
While this scenario does not necessarily exclude additional
recruitment of ventral ectoderm, it remains of interest, yet
experimentally challenging, to determine the exact extent and
directionality of ectodermal influx into each of the MRs.
How do the MRs maintain or even increase their growth rate
between E12.5 and E13.5 if both cell proliferative activity within
the MRs and ectodermal influx are declining? We show here a not
previously considered mechanism of MR growth, namely by
hypertrophy of their peripheral cells between E12.5 and E13.5.
We estimated that hypertrophy could explain perhaps a 1.7 fold
increase in MR-volume, which would equal 80%–100% of growth
in that day in a rudiment-specific manner. All estimations together
(i.e ,3%–19% proliferation +22%–39% cell migration +80%–
100% hypertrophy) add up to more than 100% of the growth
between E12.5 and E13.5, which may be partly explained by the
fact that they are estimations; partly by the possibility of a
differential contribution to the influx by the peridermal and
germinal layer of the ectoderm which have seemingly different
proliferation rates; and partly by the need of growth-promoting
mechanisms to compensate for the loss of cells by apoptosis
occurring to different extents among the MRs within themselves
and/or in their covering periderm at around E12.5.
Figure 6 shows a model of the contribution of all four
abovementioned mechanisms to MR growth. While the sequence
of mechanisms seems similar for all MRs, these mechanisms occur
asynchronously among all MRs, and contribute to different extents
to each of the MRs at any point of time. These differences may
simply reflect the asynchronous emergence of the MRs [1,18].
Alternatively, they may reflect molecular differences among the
MRs, as demonstrated by the variation in phenotype among MRs
in Gli3
Xt-J/Xt-J embryos.
Rudiment-specific roles of Gli3 in cellular processes
governing mammary rudiment growth
We identified that the five mammary rudiments (MRs) in the
mouse embryo display differential responses to the absence of Gli3:
While MR3 and MR5 are not induced at all, MR1, MR2 and
MR4 are about J day delayed in the onset of their formation.
Once induced, MR1 follows a normal growth rate and
morphogenesis, but MR2 and MR4 experience a slow growth
until at least E13.5. Moreover, MR2 protrudes outwardly instead
of invaginating into the underlying dermis. This protrusion
remains unexplained mechanistically, but may be related to the
higher proliferation rate in the dermal and mammary mesen-
chyme at E13.5 and the failure of ectoderm covering the MR to
undergo apoptosis. We could attribute the stunted growth of both
rudiments largely to a defect in ectodermal influx between E11.5
and E12.5, complemented by a failure of peripheral cells to
differentiate into hypertrophic, columnar cells between E12.5 and
E13.5.
How would Gli3 regulate these cell fate decisions? As described
below, Gli3 has been shown to play a role in proliferation, survival,
migration and hypertrophy of a variety of cell types. Depending on
cell type, it executes its role either as a full length transcriptional
activator (Gli3A) or a truncated repressor (Gli3R) form. In general,
high levels of Hedgehog (Hh) signaling maintain Gli3 as Gli3A,
leading to transcription of the Hh receptor Ptc1 and the
transcriptional activator Gli1 as a feed forward mechanism of
Hh signaling. In the absence of Hh signaling, Gli3 becomes a
transcriptional repressor (Gli3R) [32].
Hh signaling and cell-autonomously acting GliA family
members have migration promoting effects on e.g. enteric nerves,
pancreatic stellar cells and endothelial cells [33,34,35]. However, it
is very unlikely that Gli3 regulates ectodermal cell migration as
GliA, because Gli3 is not expressed in the ectoderm and
presumptive mammary epithelium at around E11.5, and although
Figure 6. A model of the role of Gli3 in regulating mammary
rudiment induction and early growth. See discussion for
explanation. Thickness of arrows relates to the relative extent of
involvement of Gli3 in a process.
doi:10.1371/journal.pone.0026242.g006
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functions as Gli3R as suggested by the absence of expression of
Ptc1 and Gli1 [9,19,36]. Instead, the migration defect during
formation and early growth of MR2 and MR4 is likely non cell-
autonomous and a consequence of perturbed mesenchymal-
ectodermal interactions due to a lack of Gli3 function in the
somites or other mesenchymal tissue [9]. We speculate this would
be a GliR function, based on increased Gli1 expression in the
mammary mesenchyme of Gli3
Xt-J/Xt-J MR2 at E13.5 (Fig. S1;
other MRs not investigated) and of MR1 and MR4 at E14.5 [9],
the lack of requirement for Shh for induction of MRs [37,38], and
similar to the requirement for Gli3R and the repression of Hh-
signaling in formation of MR3 and MR5 [19]. Along the same
line, we now assume that the failure to form MR3 and MR5 is due
to a more severe ectodermal migration defect than for MR2 and
MR4.
Similarly, our observed reduction of mammary epithelial cell
proliferation in MR2 and MR4, and apoptosis in MR2-MR5 in
the presence of Gli3 would be consistent with high Gli3R activity
repressing cell cycle progression and promoting cell apoptosis cell-
autonomously in neural progenitor cells, as reviewed [39].
During skeletogenesis, Gli3R represses differentiation of distal
chondrocytes into columnar and subsequently hypertrophic
chondrocytes [40]. If Gli3 similarly regulates the hypertrophy of
cells within MRs, the failure of peripheral cells in Gli3
Xt-J/Xt-J MR2
and MR4 to become larger columnar cells by E13.5, would
suggest Gli3 normally acts as Gli3A in these cells. Given the
unlikeliness of Gli3 being present as Gli3A in these cells, as argued
above, differentiation of the peripheral cells into larger columnar
cells in MR2 and MR4 perhaps depends non-cell-autonomously
on Gli3-mediated communicative signals emitted by the mesen-
chyme.
Summary and implications
We have answered the long-standing question of which cellular
mechanisms drive the onset of formation and early growth of MRs
in the mouse. Gli3 plays a role in all processes involved, i.e.
proliferation, migration and differentiation into hypertrophic
columnar cells, as well as apoptosis, apparently regulating the
choice between the different fates a cell can have. As Gli3 remains
expressed in the adult mammary gland [19], it may then perhaps
likewise regulate the balance between normal homeostasis and
tumor growth, as supported by the recent identification of Gli3 in
a primary breast tumor expression dataset [41], and similar to
what has recently been reviewed for several other genes [42,43].
Of note, despite the similarities among MRs regarding the cellular
mechanisms regulating their early growth, the function of Gli3 in
these mechanisms differs among the MRs, indicating MRs are not
mere copies of the same structure but distinct entities, as we have
suggested previously [2]. Such differential molecular involvement
among the various mammary glands may provide a beginning to
an explanation how differences in numbers and positions of
mammary glands are created among mammals, and simulta-
neously raise the question whether all five pairs of murine
mammary glands can be considered equally appropriate models
for the human breast.
Supporting Information
Figure S1 Gli1 mRNA expression is upregulated in
Gli3
Xt-J/Xt-J mammary mesenchyme of MR2. Bright-field
images of A: E13.5 wt and B: Gli3
Xt-J/Xt-J MR2. A9,B9:
corresponding dark-field images with the radio-active in situ
hybridization signal of a Gli1 mRNA probe in white. MRs are
outlined with dashed black lines. White arrow points at the high
hybridization signal in the mammary mesenchyme directly
underlying the Gli3
Xt-J/Xt-J MR2.
(TIF)
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